NCT03874455 2024-03-22Tazemetostat Expanded Access Program for Adults With Solid TumorsIpsenNo longer available
NCT03554434 2020-03-02An Expanded Access Program for AM0010 (Pegilodecakin)Eli Lilly and CompanyNo longer available
NCT01473043 2014-05-30Clinical Study With Axitinib In Advanced Kidney Cancer, Who Have Failed First Line TreatmentPfizerNo longer available
NCT00655252 2011-08-19Expanded Access Study of RAD001 in Metastatic Renal Cell Cancer Patients Who Are Intolerant of or Who Have Failed Despite Prior Vascular Endothelial Growth Factor TherapyNovartisNo longer available